Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Fernanda Fortes de Araujo"'
Autor:
Fernanda Fortes de Araujo, Maha Abdeladhim, Clarissa Teixeira, Kelly Hummer, Matthew D. Wilkerson, Roseanne Ressner, Ines Lakhal-Naouar, Michael W. Ellis, Claudio Meneses, Saule Nurmukhambetova, Regis Gomes, W. David Tolbert, George W. Turiansky, Marzena Pazgier, Fabiano Oliveira, Jesus G. Valenzuela, Shaden Kamhawi, Naomi Aronson
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionCutaneous leishmaniasis is a neglected vector-borne parasitic disease prevalent in 92 countries with approximately one million new infections annually. Interactions between vector saliva and the human host alter the response to infection
Externí odkaz:
https://doaj.org/article/ad6b2c84670842d0b46195dd14c3aa2c
Autor:
Fernanda Fortes de Araujo, Rana Nagarkatti, Ana Lia Mazzeti, Karolina Ribeiro Gonçalves, Lívia de Figueiredo Diniz, Isabela Campos do Vale, Olindo Assis Martins-Filho, Alain Debrabant, Maria Terezinha Bahia, Andréa Teixeira-Carvalho
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionChagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi. Although endemic mainly in Latin America, CD has become a global public health problem due to migration of infected individuals to non-endemic regions. Despite pro
Externí odkaz:
https://doaj.org/article/60fe01f1e4f84f4b87ea28d4a4c2b88a
Autor:
Fernanda Fortes de Araujo, Ines Lakhal-Naouar, Nancy Koles, Sorana Raiciulescu, Rupal Mody, Naomi Aronson
Publikováno v:
Pathogens, Vol 12, Iss 5, p 705 (2023)
Visceral leishmaniasis (VL) is a chronic infection caused by Leishmania (L.) donovani or L. infantum parasites. Despite having the infection, most individuals never develop the clinical disease and are able to control the parasite and remain asymptom
Externí odkaz:
https://doaj.org/article/302761daacdc48d19929b561a824b728
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 1, p e3451 (2015)
Drug discovery initiatives, aimed at Chagas treatment, have been hampered by the lack of standardized drug screening protocols and the absence of simple pre-clinical assays to evaluate treatment efficacy in animal models. In this study, we used a sim
Externí odkaz:
https://doaj.org/article/f531793561e24b30b3ae998a996b8232
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 1, p e2650 (2014)
Chagas disease affects about 5 million people across the world. The etiological agent, the intracellular parasite Trypanosoma cruzi (T. cruzi), can be diagnosed using microscopy, serology or PCR based assays. However, each of these methods has their
Externí odkaz:
https://doaj.org/article/2bbd85133e5e46dd86c588f08a3270ca
Autor:
Rana Nagarkatti, Vaibhav Bist, Sirena Sun, Fernanda Fortes de Araujo, Hira L Nakhasi, Alain Debrabant
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43533 (2012)
Trypanosoma cruzi, a blood-borne parasite, is the etiological agent of Chagas disease. T. cruzi trypomastigotes, the infectious life cycle stage, can be detected in blood of infected individuals using PCR-based methods. However, soon after a natural
Externí odkaz:
https://doaj.org/article/f38b66785e0f4727b6990cf169390fa7
Autor:
Isabela Natália Pascoal Campos do Vale, Gregório Guilherme Almeida, Inga Rimkute, Thomas Liechti, Fernanda Fortes de Araújo, Luara Isabela dos Santos, Priscilla Miranda Henriques, Manoel Otávio da Costa Rocha, Silvana Maria Elói-Santos, Olindo Assis Martins−Filho, Mario Roederer, Alan Sher, Dragana Jankovic, Andréa Teixeira−Carvalho, Lis Ribeiro do Valle Antonelli
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChagas disease is a neglected parasitic disease caused by Trypanosoma cruzi. While most patients are asymptomatic, around 30% develop Chronic Chagasic Cardiomyopathy (CCC).MethodsHere, we employed high-dimensional flow cytometry to analyz
Externí odkaz:
https://doaj.org/article/5bd4e3082c7140d1a77c7286aed79c20
Autor:
Helton C. Santiago, Joseph D. Weaver, Victoria Hoffman, Wuzhou Wan, Ana Paula M. P. Marino, Ester Roffê, Philip M. Murphy, Fernanda Fortes de Araujo
Publikováno v:
Infection and Immunity. 84:1123-1136
Infectious agents are often considered potential triggers of chronic inflammatory disease, including autoimmunity; however, direct evidence is usually lacking. Here we show that following control of acute infection of mice with the myotropic Colombia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b228722cd6488a482b04f35949ad9e35
https://doi.org/10.1128/iai.01497-15
https://doi.org/10.1128/iai.01497-15
Autor:
Gregório Guilherme Almeida, Inga Rimkute, Isabela Natália Pascoal Campos do Vale, Thomas Liechti, Priscilla Miranda Henriques, Ester Roffe, Fernanda Fortes de Araújo, Manoel Otávio da Costa Rocha, Silvana Maria Elói Santos, Olindo Assis Martins-Filho, Dragana Jankovic, Alan Sher, Andrea Teixeira-Carvalho, Mario Roederer, Lis Ribeiro do Valle Antonelli
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-17 (2022)
Abstract Chagas disease is a neglected tropical disease in Latin America and an imported emerging disease worldwide. Chronic Chagas disease cardiomyopathy (CCC) is the most prominent clinical form and can lead to heart failure, thromboembolism, and s
Externí odkaz:
https://doaj.org/article/aa324dd66d3b4791bbf86e126ddfd1d3
Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood
Autor:
Hira L. Nakhasi, Vaibhav Bist, Fernanda Fortes de Araujo, Sirena Sun, Alain Debrabant, Rana Nagarkatti
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e43533 (2012)
PLoS ONE, Vol 7, Iss 8, p e43533 (2012)
Trypanosoma cruzi, a blood-borne parasite, is the etiological agent of Chagas disease. T. cruzi trypomastigotes, the infectious life cycle stage, can be detected in blood of infected individuals using PCR-based methods. However, soon after a natural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f98468b6ff0a1213433bb7e7e1bcdb5e
https://pubmed.ncbi.nlm.nih.gov/22927983
https://pubmed.ncbi.nlm.nih.gov/22927983